Invesco’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.74M Sell
70,888
-183,598
-72% -$25.2M ﹤0.01% 1786
2025
Q1
$45.9M Sell
254,486
-20,709
-8% -$3.73M 0.01% 1071
2024
Q4
$43.1M Sell
275,195
-90,356
-25% -$14.2M 0.01% 1115
2024
Q3
$66.5M Buy
365,551
+90,474
+33% +$16.5M 0.01% 931
2024
Q2
$50.5M Buy
275,077
+185,449
+207% +$34.1M 0.01% 1006
2024
Q1
$15.9M Buy
89,628
+35,399
+65% +$6.3M ﹤0.01% 1560
2023
Q4
$6.73M Buy
54,229
+10,030
+23% +$1.24M ﹤0.01% 2070
2023
Q3
$5.13M Sell
44,199
-21,009
-32% -$2.44M ﹤0.01% 2194
2023
Q2
$7.66M Buy
65,208
+13,628
+26% +$1.6M ﹤0.01% 1988
2023
Q1
$4.13M Buy
51,580
+23,537
+84% +$1.88M ﹤0.01% 2309
2022
Q4
$2.22M Sell
28,043
-23,565
-46% -$1.87M ﹤0.01% 2595
2022
Q3
$3.6M Buy
51,608
+42,454
+464% +$2.96M ﹤0.01% 2373
2022
Q2
$600K Buy
9,154
+1,404
+18% +$92K ﹤0.01% 3222
2022
Q1
$515K Buy
7,750
+69
+0.9% +$4.59K ﹤0.01% 3341
2021
Q4
$538K Sell
7,681
-455
-6% -$31.9K ﹤0.01% 3323
2021
Q3
$425K Buy
8,136
+931
+13% +$48.6K ﹤0.01% 3472
2021
Q2
$489K Buy
7,205
+3,454
+92% +$234K ﹤0.01% 3405
2021
Q1
$289K Buy
+3,751
New +$289K ﹤0.01% 3546
2020
Q2
Sell
-34,701
Closed -$1.5M 3625
2020
Q1
$1.5M Sell
34,701
-47,632
-58% -$2.06M ﹤0.01% 2543
2019
Q4
$4.56M Buy
82,333
+35,123
+74% +$1.95M ﹤0.01% 2215
2019
Q3
$1.64M Buy
+47,210
New +$1.64M ﹤0.01% 2717
2019
Q1
Sell
-47,113
Closed -$979K 3706
2018
Q4
$979K Buy
+47,113
New +$979K ﹤0.01% 2971